Holdbrook Mark J.
- SEC CIK
- 0001827564
No open-market purchases or sales filed in the past year.
Current role at each company
- TARS Tarsus Pharmaceuticals, Inc.V.P., Clinical Affairsas of Mar 21, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Holdbrook Mark J. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 21, 2023 (view filing) | Mar 17-20 | 4 days | Holdbrook Mark J.V.P., Clinical Affairs | SSale | −386 | $12.94 | −$4.99K | −10.8%3.19K after | 2 lots |
| Mar 17, 2023 (view filing) | Mar 16 | 1 day | Holdbrook Mark J.V.P., Clinical Affairs | SSale | −187 | $13.43 | −$2.51K | −5.0%3.58K after |